BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8621771)

  • 1. Induction of a negative autocrine loop by expression of sst2 somatostatin receptor in NIH 3T3 cells.
    Rauly I; Saint-Laurent N; Delesque N; Buscail L; Estéve JP; Vaysse N; Susini C
    J Clin Invest; 1996 Apr; 97(8):1874-83. PubMed ID: 8621771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis.
    Guillermet J; Saint-Laurent N; Rochaix P; Cuvillier O; Levade T; Schally AV; Pradayrol L; Buscail L; Susini C; Bousquet C
    Proc Natl Acad Sci U S A; 2003 Jan; 100(1):155-60. PubMed ID: 12490654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2.
    Buscail L; Delesque N; Estève JP; Saint-Laurent N; Prats H; Clerc P; Robberecht P; Bell GI; Liebow C; Schally AV
    Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2315-9. PubMed ID: 7907795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238.
    Benali N; Cordelier P; Calise D; Pages P; Rochaix P; Nagy A; Esteve JP; Pour PM; Schally AV; Vaysse N; Susini C; Buscail L
    Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9180-5. PubMed ID: 10900262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tyrosine phosphatase SHP-1 associates with the sst2 somatostatin receptor and is an essential component of sst2-mediated inhibitory growth signaling.
    Lopez F; Estève JP; Buscail L; Delesque N; Saint-Laurent N; Théveniau M; Nahmias C; Vaysse N; Susini C
    J Biol Chem; 1997 Sep; 272(39):24448-54. PubMed ID: 9305905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. sst2 somatostatin receptor expression reverses tumorigenicity of human pancreatic cancer cells.
    Delesque N; Buscail L; Estève JP; Saint-Laurent N; Müller C; Weckbecker G; Bruns C; Vaysse N; Susini C
    Cancer Res; 1997 Mar; 57(5):956-62. PubMed ID: 9041201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for pancreatic carcinoma: local and distant antitumor effects after somatostatin receptor sst2 gene transfer.
    Rochaix P; Delesque N; Estève JP; Saint-Laurent N; Voight JJ; Vaysse N; Susini C; Buscail L
    Hum Gene Ther; 1999 Apr; 10(6):995-1008. PubMed ID: 10223733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role of Src and SHP-2 in sst2 somatostatin receptor-mediated activation of SHP-1 and inhibition of cell proliferation.
    Ferjoux G; Lopez F; Esteve JP; Ferrand A; Vivier E; Vely F; Saint-Laurent N; Pradayrol L; Buscail L; Susini C
    Mol Biol Cell; 2003 Sep; 14(9):3911-28. PubMed ID: 12972574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activation of the phosphotyrosine phosphatase eta (r-PTP eta) is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation.
    Florio T; Arena S; Thellung S; Iuliano R; Corsaro A; Massa A; Pattarozzi A; Bajetto A; Trapasso F; Fusco A; Schettini G
    Mol Endocrinol; 2001 Oct; 15(10):1838-52. PubMed ID: 11579215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
    Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C
    Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel synergistic mechanism for sst2 somatostatin and TNFalpha receptors to induce apoptosis: crosstalk between NF-kappaB and JNK pathways.
    Guillermet-Guibert J; Saint-Laurent N; Davenne L; Rochaix P; Cuvillier O; Culler MD; Pradayrol L; Buscail L; Susini C; Bousquet C
    Cell Death Differ; 2007 Feb; 14(2):197-208. PubMed ID: 16645635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer.
    Buscail L; Saint-Laurent N; Chastre E; Vaillant JC; Gespach C; Capella G; Kalthoff H; Lluis F; Vaysse N; Susini C
    Cancer Res; 1996 Apr; 56(8):1823-7. PubMed ID: 8620499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal nitric oxide synthase: a substrate for SHP-1 involved in sst2 somatostatin receptor growth inhibitory signaling.
    Lopez F; Ferjoux G; Cordelier P; Saint-Laurent N; Estève JP; Vaysse N; Buscail L; Susini C
    FASEB J; 2001 Oct; 15(12):2300-2. PubMed ID: 11511520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory role of the somatostatin receptor SST2 on the intracrine-regulated cell proliferation induced by the 210-amino acid fibroblast growth factor-2 isoform: implication of JAK2.
    Hortala M; Ferjoux G; Estival A; Bertrand C; Schulz S; Pradayrol L; Susini C; Clemente F
    J Biol Chem; 2003 Jun; 278(23):20574-81. PubMed ID: 12665520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of somatostatin receptor type-2 (sst2A) in immature porcine Leydig cells and a possible role in the local control of testosterone secretion.
    Fombonne J; Csaba Z; von Boxberg Y; Valayer A; Rey C; Benahmed M; Dournaud P; Krantic S
    Reprod Biol Endocrinol; 2003 Feb; 1():19. PubMed ID: 12646058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of antiproliferative effect of somatostatin: involvement of a tyrosine phosphatase.
    Lopez F; Estève JP; Buscail L; Delesque N; Saint-Laurent N; Vaysse N; Susini C
    Metabolism; 1996 Aug; 45(8 Suppl 1):14-6. PubMed ID: 8769371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogene transformation of PC Cl3 clonal thyroid cell line induces an autonomous pattern of proliferation that correlates with a loss of basal and stimulated phosphotyrosine phosphatase activity.
    Florio T; Scorziello A; Thellung S; Salzano S; Berlingieri MT; Fusco A; Schettini G
    Endocrinology; 1997 Sep; 138(9):3756-63. PubMed ID: 9275062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory and stimulatory effects of somatostatin on two human pancreatic cancer cell lines: a primary role for tyrosine phosphatase SHP-1.
    Douziech N; Calvo E; Coulombe Z; Muradia G; Bastien J; Aubin RA; Lajas A; Morisset J
    Endocrinology; 1999 Feb; 140(2):765-77. PubMed ID: 9927304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tyrosine phosphatase is associated with the somatostatin receptor.
    Delesque N; Buscail L; Estève JP; Rauly I; Zeggari M; Saint-Laurent N; Bell GI; Schally AV; Vaysse N; Susini C
    Ciba Found Symp; 1995; 190():187-96; discussion 196-203. PubMed ID: 7587647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the bystander effect of somatostatin receptor sst2 after in vivo gene transfer into human pancreatic cancer cells.
    Carrere N; Vernejoul F; Souque A; Asnacios A; Vaysse N; Pradayrol L; Susini C; Buscail L; Cordelier P
    Hum Gene Ther; 2005 Oct; 16(10):1175-93. PubMed ID: 16218779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.